Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study

Autor: van Atteveld, Jenneke E ^*, de Winter, Demi T C ^{*, *}, Pluimakers, Vincent G, Fiocco, Marta, Nievelstein, Rutger A J, Hobbelink, Monique G G, de Vries, Andrica C H, Loonen, Jacqueline J, van Dulmen-den Broeder, Eline, van der Pal, Helena J, Pluijm, Saskia M F, Kremer, Leontien C M, Ronckers, Cécile M, van der Heiden-van der Loo, Margriet, Versluijs, A Birgitta, Louwerens, Marloes, Bresters, Dorine, van Santen, Hanneke M, Olsson, Daniel S, Hoefer, Imo, van den Berg, Sjoerd A A, den Hartogh, Jaap, Tissing, Wim J E, Neggers, Sebastian J C M M, van den Heuvel-Eibrink, Marry M

Publikováno v: In The Lancet Diabetes & Endocrinology January 2023 11(1):21-32

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Frailty and Sarcopenia within the Earliest Dutch Childhood Cancer Survivor Cohort (n=2,003): A Dccss-Later Study

Autor: van Atteveld, Jenneke E. ^*, de Winter, Demi T.C. ^*, Pluimakers, Vincent G. ^*, Fiocco, Marta ^*, Nievelstein, Rutger A.J. ^*, Hobbelink, Monique G.G. ^*, Kremer, Leontien C.M. ^*, Ronckers, Cécile M. ^*, Grootenhuis, Martha A. ^*, Maurice-Stam, Heleen ^*, Tissing, Wim J.E. ^*, de Vries, Andrica C.H., Loonen, Jacqueline J. ^*, Van Dulmen-den Broeder, Eline ^*, van der Pal, Helena J. ^*, Pluijm, Saskia ^*, van der Heiden-van der Loo, Margriet ^*, Versluys, Birgitta ^*, Louwerens, Marloes ^*, Bresters, Dorine ^*, van Santen, Hanneke M. ^*, Hoefer, Imo ^*, van den Berg, Sjoerd A.A. ^*, Hoeijmakers, Jan H.J. ^*, Neggers, Sebastian J.C.M.M. ^*, van den Heuvel-Eibrink, Marry M.

Publikováno v: In Blood 15 November 2022 140 Supplement 1:6026-6027

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Frailty and sarcopenia within the earliest national Dutch childhood cancer survivor cohort (DCCSS-LATER): a cross-sectional study.

Autor: van Atteveld JE; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands. Electronic address: J.E.vanAtteveld@prinsesmaximacentrum.nl., de Winter DTC; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Pluimakers VG; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Medical Statistics Section, Department of Biomedical Data Science, Leiden University Medical Center, Leiden, Netherlands; Mathematical Institute, Leiden University, Leiden, Netherlands., Nievelstein RAJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Hobbelink MGG; Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands; Emma Children's Hospital, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., Grootenhuis MA; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Maurice-Stam H; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, University of Groningen, University Medical Center Groningen, Groningen, Netherlands., de Vries ACH; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Oncology, Sophia Children's Hospital, Erasmus Medical Center, Rotterdam, Netherlands., Loonen JJ; Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands., van Dulmen-den Broeder E; Department of Pediatric Oncology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., van der Heiden-van der Loo M; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Dutch Childhood Oncology Group, Utrecht, Netherlands., Versluijs AB; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands., Louwerens M; Department of Internal Medicine, Leiden University Medical Center, Leiden, Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, Netherlands., van Santen HM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Pediatric Endocrinology, University Medical Center Utrecht, Utrecht, Netherlands., Hoefer I; Central Diagnostic Laboratory, University Medical Center Utrecht, Utrecht, Netherlands., van den Berg SAA; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, Netherlands; Department of Internal Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands., den Hartogh J; Dutch Childhood Cancer Organisation, De Bilt, Netherlands., Hoeijmakers JHJ; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Oncode Institute and Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, Netherlands., Neggers SJCMM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Department of Internal Medicine, Section Endocrinology, Erasmus Medical Center, Rotterdam, Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands; Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht, Netherlands.

Publikováno v: The lancet. Healthy longevity [Lancet Healthy Longev] 2023 Apr; Vol. 4 (4), pp. e155-e165.